J&J Sees 2024 Sales Growth Slowing as Top Drug Faces Competition
Bloomberg· 3 小時前Johnson & Johnson expects operational sales growth between 5% to 6% in 2024 as its top-selling psoriasis drug starts to ...
Emcure wins dismissal of US lawsuit over COVID-19 vaccine trade secrets
Reuters· 16 小時前Generic drugmaker Emcure Pharmaceuticals (EMCU.NS) convinced a federal court in Seattle, ...
Governments take action to keep offshore wind projects on track
Reuters· 9 小時前Governments have decided to pay up to revive offshore wind farm developments after rising costs ...
23andMe confirms hackers stole ancestry data on 6.9 million users
TechCrunch· 21 小時前On Friday, genetic testing company 23andMe announced that hackers accessed the personal data of ...
US Supreme Court wrestles with OxyContin maker’s bankruptcy deal
South China Morning Post· 16 小時前Justice Elena Kagan seemed to sum up the questions that were nagging at some of the justices. ...
'Animate Anyone' heralds the approach of full-motion deepfakes
TechCrunch· 17 小時前As if still-image deepfakes aren’t bad enough, we may soon have to contend with generated ...
Sandra Day O’Connor’s unfinished legacy of judicial election reform
Reuters· 19 小時前As is, our system for electing state and local judges often comes down to who raises the most ...
China rolls out major rural bank overhaul amid ongoing financial risk prevention push - Dimsum Daily
Dimsum Daily· 23 小時前4th December 2023 – (Beijing) China has merged approximately 130 small lenders into a single ...
The Pentagon Wants to Root Out Shoddy Drugs. The FDA Is In Its Way.
Bloomberg· 15 小時前One morning in October, US Army Colonel Victor Suarez finished his usual morning workout — a ...